BSEC — Biosecurity Technology Income Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsMicro Cap
Annual income statement for Biosecurity Technology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0.002 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Total Operating Expenses | 0.01 | 0.016 | 0.029 |
| Operating Profit | -0.008 | -0.016 | -0.029 |
| Net Income Before Taxes | -0.008 | -0.016 | -0.029 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.008 | -0.016 | -0.029 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.008 | -0.016 | -0.029 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.008 | -0.016 | -0.029 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.001 | -0.002 | -0.004 |
| Dividends per Share |